Induction of Mucosal Tolerance in SLE: a Sniff or a Sip Away from Ameliorating Lupus?

Overview

Journal Clin Immunol

Specialty Allergy & Immunology

Date 2008 Oct 22

PMID 18938110

Citations 4

Authors

Henry Yim Wu

Affiliations

Soon will be listed here.

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by aberrant immune responses against intracellularly derived self antigens. Treatment for SLE relies on the use of aggressive immunosuppressants and steroids that are nonspecific and can cause serious adverse effects. The observation that a systemic immune tolerance to self antigens or generation of regulatory T cells may follow mucosal (nasal or oral) exposure to self proteins or monoclonal antibody against CD3 respectively suggests that induction of mucosal tolerance offers the basis of a side effect-free therapy that could re-establish the ability to distinguish self from non-self and restore peripheral tolerance in individuals susceptible to developing autoimmune diseases. Here I review studies on mucosal tolerance in autoimmune diseases and discuss the therapeutic potential of inducing tolerance for the treatment of SLE.

Citing Articles

Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH.

Ilan Y, Shailubhai K, Sanyal A Clin Exp Immunol. 2018; 193(3):275-283.

PMID: 29920654 PMC: 6150260. DOI: 10.1111/cei.13159.

Ameliorating Role Exerted by Al-Hijamah in Autoimmune Diseases: Effect on Serum Autoantibodies and Inflammatory Mediators.

Baghdadi H, Abdel-Aziz N, Ahmed N, Mahmoud H, Barghash A, Nasrat A Int J Health Sci (Qassim). 2015; 9(2):207-32.

PMID: 26309442 PMC: 4538900.

Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.

Wu H, Maron R, Tukpah A, Weiner H J Immunol. 2010; 185(6):3401-7.

PMID: 20720210 PMC: 2962584. DOI: 10.4049/jimmunol.1000836.

Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.

Yu M, Vajdy M Expert Opin Biol Ther. 2010; 10(8):1181-95.

PMID: 20624114 PMC: 2904634. DOI: 10.1517/14712598.2010.496776.

References

Abramowicz D, Schandene L, Goldman M, Crusiaux A, Vereerstraeten P, De Pauw L . Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation. 1989; 47(4):606-8. DOI: 10.1097/00007890-198904000-00008. View

Gautam S, Chikkala N, BATTISTO J . Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population. Cell Immunol. 1990; 125(2):437-48. DOI: 10.1016/0008-8749(90)90097-b. View

Zhang Z, Michael J . Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment. J Immunol. 1990; 144(11):4163-5. View

Khoury S, Hancock W, Weiner H . Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,.... J Exp Med. 1992; 176(5):1355-64. PMC: 2119419. DOI: 10.1084/jem.176.5.1355. View

Weiner H, Mackin G, Matsui M, Orav E, Khoury S, Dawson D . Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science. 1993; 259(5099):1321-4. DOI: 10.1126/science.7680493. View

Hoyne G, Callow M, Kuhlman J, Thomas W . T-cell lymphokine response to orally administered proteins during priming and unresponsiveness. Immunology. 1993; 78(4):534-40. PMC: 1421882. View

Trentham D, Orav E, Combitchi D, Lorenzo C, Sewell K, Hafler D . Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993; 261(5129):1727-30. DOI: 10.1126/science.8378772. View

Miller A, Al-Sabbagh A, Santos L, Das M, Weiner H . Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol. 1993; 151(12):7307-15. View

Friedman A, Weiner H . Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A. 1994; 91(14):6688-92. PMC: 44268. DOI: 10.1073/pnas.91.14.6688. View

10.

Chen Y, Kuchroo V, Inobe J, Hafler D, Weiner H . Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994; 265(5176):1237-40. DOI: 10.1126/science.7520605. View

11.

Friedman A, Weiner H . Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice. Eur J Immunol. 1994; 24(11):2720-4. DOI: 10.1002/eji.1830241122. View

12.

Aroeira L, Cardillo F, de Albuquerque D, Vaz N, Mengel J . Anti-IL-10 treatment does not block either the induction or the maintenance of orally induced tolerance to OVA. Scand J Immunol. 1995; 41(4):319-23. DOI: 10.1111/j.1365-3083.1995.tb03573.x. View

13.

McMenamin C, McKersey M, Kuhnlein P, Hunig T, Holt P . Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol. 1995; 154(9):4390-4. View

14.

Hoyne G, Thomas W . T-cell responses to orally administered antigens. Study of the kinetics of lymphokine production after single and multiple feeding. Immunology. 1995; 84(2):304-9. PMC: 1415102. View

15.

Barone K, Jain S, Michael J . Effect of in vivo depletion of CD4+ and CD8+ cells on the induction and maintenance of oral tolerance. Cell Immunol. 1995; 163(1):19-29. DOI: 10.1006/cimm.1995.1094. View

16.

Garside P, Steel M, Liew F, Mowat A . CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int Immunol. 1995; 7(3):501-4. DOI: 10.1093/intimm/7.3.501. View

17.

Chen Y, Inobe J, Weiner H . Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol. 1995; 155(2):910-6. View

18.

Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M . Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995; 155(3):1151-64. View

19.

Houssiau F, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer J, Renauld J . Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus. 1995; 4(5):393-5. DOI: 10.1177/096120339500400510. View

20.

Nelson P, Akselband Y, Dearborn S, Al-Sabbagh A, Tian Z, Gonnella P . Effect of oral beta interferon on subsequent immune responsiveness. Ann N Y Acad Sci. 1996; 778:145-55. DOI: 10.1111/j.1749-6632.1996.tb21123.x. View